Syros Pharmaceuticals Inc (SYRS) Return on Assets ROA from the third quarter of 2024 to third quarter of 2023 and for the year 2024, Average High and Low, Fundamental Ratios from Sep 30 2024 to Sep 30 2023 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Syros Pharmaceuticals Inc   (NASDAQ: SYRS)


Syros Pharmaceuticals Inc 's ROA from the third quarter of 2024 to the third quarter of 2023 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Syros Pharmaceuticals Inc 's ROA in the third quarter of 2024?
Syros Pharmaceuticals Inc recorded a cumulative net loss of $-98 million during 12 months ending in the third quarter of 2024, resulting in a negative return on assets (ROA) of -86.43%.

However, within the Healthcare sector 766 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2024 quarter, so far to 4508, from total ROA ranking in the second quarter of 2024 at 4630.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter
Y / Y Total Assets Change -45.41 % -42.8 % -36.16 % -32.11 % -49.82 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -98 -132 -144 -165 -105
Return On Assets (TTM) -86.43 % -102.27 % -98.48 % -100.15 % -57.38 %
SYRS's Total Ranking # 4508 # 4630 # 4682 # 5435 # 4521
Total Assets (TTM) in million 74 97 124 157 136
Seq. Total Assets Change -23.08 % -22.22 % -21.04 % 15.55 % -19.41 %
Seq. Net Income Change - - - - -

SYRS's 5 Years Annual ROA >> Back to SYRS Management Effectiveness >> Compare SYRS ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 356
Sector # 767
Overall # 4424

Return On Assets Statistics
High Average Low
-39.11 %
-57.17 %
-94.41 %
(Dec 31 2021)   (Jun 30 2024)





Financial Statements
Syros Pharmaceuticals Inc 's Assets $ 74 million SYRS's Balance sheet
Syros Pharmaceuticals Inc 's Income $ -6 million Quarterly SYRS's Income Statement
SYRS's Income by Division See SYRS's Income by Division



Annual Return On Assets (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020		 (Dec 31 2019)
FY 2019
Y / Y Total Assets Change -32.11 % 36.73 % -15.16 % 33.41 % 40.32 %
Total Assets in million 157 232 170 200 150
Y / Y Net Income Change - - - - -
Net Income in million -165 -95 -87 -84 -75
Annual Return On Assets -104.56 % -40.83 % -51.05 % -42.05 % -50.36 %

SYRS's 5 Years Annual ROA >> Back to SYRS Management Effectiveness >> Compare SYRS ROA to its Competitors



More Return On Assets Ratios
SYRS's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
SYRS's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for SYRS's Competitors
Subscribers only: Roa for Syros Pharmaceuticals Inc 's Suppliers
Subscribers only: Return On Assets for SYRS's Customers

You may also want to know
SYRS's Roi SYRS's Inventory Turnover Ratio SYRS's Growth Rates SYRS's Dividend Comparisons
SYRS's Profitability Ratios SYRS's Asset Turnover Ratio SYRS's Dividend Growth
SYRS's Roe SYRS's Valuation Ratios SYRS's Financial Strength Ratios SYRS's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2024, within Healthcare Sector ROA

Date modified: 2026-09-26T07:31:38+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.